Sensitive Detection of Gamma-H2AX Induction as a Pharmacodynamic Marker for Profiling Patients With Cancer Treated With Topotecan
American Society of Clinical Oncology
FDA Veteran Paz Vellanki, MD, joins Precision to become one of 3 ex-FDA oncology leaders supporting clients
Peer-reviewed articles and conference poster presentations
Poster
Download Poster
Poster
Download Poster
Poster
Download Poster
Poster
Download Poster
Poster
Download Poster
Poster
Download Poster
Poster
Download Poster
Poster
Download Poster